An Observational Study to Determine Whether Routinely Sending Patients Home With a 24-Hour Supply of Topical Tetracaine From the Emergency Department for Simple Corneal Abrasion Pain Is Potentially Safe Neil Waldman, MD, Ben Winrow, MBCHB, Ian Densie, BSR, Andrew Gray, BA, BCom, Scott McMaster, DO, George Giddings, MBCH, John Meanley, MBCHB Annals of Emergency Medicine Volume 71, Issue 6, Pages 767-778 (June 2018) DOI: 10.1016/j.annemergmed.2017.02.016 Copyright © 2017 American College of Emergency Physicians Terms and Conditions
Figure 1 Reported tetracaine-specific uncommon adverse events. Annals of Emergency Medicine 2018 71, 767-778DOI: (10.1016/j.annemergmed.2017.02.016) Copyright © 2017 American College of Emergency Physicians Terms and Conditions
Figure 2 Variables used to calculate the probability for the propensity scores. Annals of Emergency Medicine 2018 71, 767-778DOI: (10.1016/j.annemergmed.2017.02.016) Copyright © 2017 American College of Emergency Physicians Terms and Conditions
Figure 3 Patient flow through the study. Annals of Emergency Medicine 2018 71, 767-778DOI: (10.1016/j.annemergmed.2017.02.016) Copyright © 2017 American College of Emergency Physicians Terms and Conditions
Figure 4 Adoption of tetracaine use for SCA, February 2014 to October 2015. Annals of Emergency Medicine 2018 71, 767-778DOI: (10.1016/j.annemergmed.2017.02.016) Copyright © 2017 American College of Emergency Physicians Terms and Conditions